Recombinant Human ARHGDIB Protein, N-His

Introduction

Recombinant Human ARHGDIB Protein, also known as Rho GDP-dissociation inhibitor 2 (RhoGDI2), is a type of protein that plays a crucial role in regulating the activity of Rho GTPases. Rho GTPases are a family of small G proteins that are involved in various cellular processes, such as cell motility, adhesion, and proliferation. The ARHGDIB protein acts as an inhibitor of Rho GTPases, preventing their activation and subsequent downstream signaling. This protein is produced through recombinant technology, making it a valuable tool for scientific research and potential therapeutic applications.

Structure of Recombinant Human ARHGDIB Protein

The recombinant human ARHGDIB protein is a 23-kDa protein composed of 204 amino acids. It has a conserved RhoGDI domain, which is essential for its function as a Rho GTPase inhibitor. This domain contains a hydrophobic pocket that binds to the prenyl group of Rho GTPases, preventing their interaction with their downstream effectors. Additionally, the ARHGDIB protein also has a C-terminal extension that is unique to this protein and is thought to play a role in its regulation.

Activity of Recombinant Human ARHGDIB Protein

The main function of recombinant human ARHGDIB protein is to inhibit the activity of Rho GTPases. Rho GTPases are activated by the addition of a phosphate group, which allows them to interact with downstream effector proteins and initiate signaling cascades. The ARHGDIB protein binds to the prenyl group of Rho GTPases, preventing their activation and subsequent signaling. This inhibition is reversible, allowing for tight regulation of Rho GTPase activity.

In addition to its role as a Rho GTPase inhibitor, the ARHGDIB protein has also been found to interact with other proteins, such as the EGF receptor and the c-Src tyrosine kinase. These interactions suggest that the ARHGDIB protein may have additional functions beyond Rho GTPase regulation, which require further investigation.

Applications of Recombinant Human ARHGDIB Protein

Recombinant human ARHGDIB protein has a wide range of applications in scientific research. Its ability to inhibit Rho GTPases makes it a valuable tool for studying the role of these proteins in various cellular processes. For example, researchers can use this protein to investigate the effects of Rho GTPase inhibition on cell motility, adhesion, and proliferation. Additionally, the ARHGDIB protein can be used to study the downstream signaling pathways of Rho GTPases and their interactions with other proteins.

Furthermore, the ARHGDIB protein has potential therapeutic applications. As Rho GTPases are involved in various diseases, such as cancer and cardiovascular diseases, the ARHGDIB protein can be used as a potential target for drug development. By inhibiting Rho GTPase activity, the ARHGDIB protein may be able to prevent or treat these diseases. However, further research is needed to fully understand the potential of the ARHGDIB protein as a therapeutic target.

Conclusion

In summary, recombinant human ARHGDIB protein is a valuable tool for scientific research and has potential therapeutic applications. Its structure, activity, and role as a Rho GTPase inhibitor make it a crucial protein in regulating various cellular processes. As research on this protein continues, we may discover new functions and applications for this protein, further expanding our understanding of its role in cellular biology.